ketamine and semaglutide Discovering Hope: Treatments Exploring the Benefits of Ketamine

#Pharma #GLP1 #ObesityTreatment #DrugDevelopment #HealthcareInnovation #EliLilly #NovoNordisk #PharmaceuticalIndustry To view or add a comment, sign in NEW DRUG APPROVAL ALERT The FDA has approved Foundayo (orforglipron), a new once-daily oral GLP-1 for chronic weight management in adults with obesity, or adults with overweight plus at least one weight-related condition

MASH, which is also known as non-alcoholic fatty liver disease, occurs when excess fat builds up in the liver and damages organs

New protocols with interferon (Intron A) and other immunotherapies are being investigated

Here are some of the most notable potential benefits of Dihexa peptide: Cognitive Function: Early research suggests that Dihexa may have the potential to enhance cognitive functions such as learning, memory, and overall mental acuity

10.1016/S0140-6736(70)92781-9 43

All GLP-1 medications are administered via injection with varying frequency